Eilmeldung
RUStrait of Hormuz Closed Amid Regional Escalation, PSGA AnnouncesRUВ Чернигове прогремели три взрыва на фоне воздушной тревогиESIsrael y EEUU contra Irán por el Estrecho de OrmuzSEPensionerad militär bor kvar intill Europas nya stålverkITFinale di Wimbledon: Sinner contro Zverev per il titoloRUРоссийская армия нанесла групповые удары по портовой инфраструктуре УкраиныDEAlexander Zverevs Wimbledon-Final-Einzug: Petkovic analysiert seine VerbesserungenBRMãe dá à luz dentro de ônibus na BR-153 em Ubarana (SP) com ajuda de policiaisBRDois homens presos por roubo no Louvre dizem que receberiam até 25 mil eurosBRHomem morre após choque elétrico em AraguatinsRUStrait of Hormuz Closed Amid Regional Escalation, PSGA AnnouncesRUВ Чернигове прогремели три взрыва на фоне воздушной тревогиESIsrael y EEUU contra Irán por el Estrecho de OrmuzSEPensionerad militär bor kvar intill Europas nya stålverkITFinale di Wimbledon: Sinner contro Zverev per il titoloRUРоссийская армия нанесла групповые удары по портовой инфраструктуре УкраиныDEAlexander Zverevs Wimbledon-Final-Einzug: Petkovic analysiert seine VerbesserungenBRMãe dá à luz dentro de ônibus na BR-153 em Ubarana (SP) com ajuda de policiaisBRDois homens presos por roubo no Louvre dizem que receberiam até 25 mil eurosBRHomem morre após choque elétrico em Araguatins
Newsgather
BackKerala HC Case on Breast Cancer Drug Access Listed 57 Times Without Hearing
Kerala HC Case on Breast Cancer Drug Access Listed 57 Times Without Hearing
Dringend
Times of India1 g önceLawIndia

Kerala HC Case on Breast Cancer Drug Access Listed 57 Times Without Hearing

Auf einen Blick

  • A Kerala High Court case seeking access to life-saving breast cancer drug Ribociclib, filed in 2022, has been listed 57 times without a hearing.
  • The petitioner died during the case, which the court continued suo motu due to public interest.
  • A working group has urged the Chief Justice of India to expedite the hearing.

KI-generierte Zusammenfassung

Schriftgröße

A Kerala High Court case seeking access to life-saving breast cancer drug Ribociclib, filed in 2022, has been listed 57 times without a hearing. The petitioner died during the case, which the court continued suo motu due to public interest. A working group has urged the Chief Justice of India to expedite the hearing.

Read the full article on Times of India

Verwandte Themen

This article was originally published by Times of India.

Ähnliche Meldungen

Mehr zu diesem Themabreast cancer